Republicans Favor Regulatory ‘Leeway’ On Drug Use During Emergencies, Bright Hearing Shows
In a Congressional hearing reminiscent of the right-to-try law debates, Democrats praised ousted BARDA Director Rick Bright for whistleblowing on the political interference in COVID-19 drug decisions, while Republicans argued the government should lower its standards during a pandemic and permit more widespread use of experimental medicines prior to clinical data.
